Table 1 Patients and incidence of Ki-ras mutations in plasma DNA

From: Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes

No.

Sex

Age (years)

Tumour site

Tumour stage

Histological type

Surgery

Survival

WT

Mut

11

M

67

NA

IVb

DAC

No

9

2

5

13

M

81

Head

Metastases

DAC

No

6

5

0

16

M

70

Head

IVb

NA

No

35

10

0

29

M

51

Head

Metastases

DAC (moderate)

No

5

3

0

34

M

50

Head

Metastases

DAC (poorly)

No

8

3

3

37

F

69

Head

T2, N1, M1

NA

No

23

9

0

38

F

57

Head

Metastases

DAC (moderate)

No

6

4

0

39

M

59

Head

Metastases

DAC (moderate)

Yes

83

1

1

40

F

71

Head

T3, N1, M1

DAC (moderate/poorly)

Yes

43

9

0

43

M

52

Head

Metastases

DAC (moderate)

No

14

0

9

  1. DAC=ductal adenocarcinoma; NA=data not available; Survival=survival in months after diagnosis; WT=wild-type (number of samples); Mut=mutation (number of samples).